A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency

NCT02476916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Pyruvate Kinase Deficiency

Interventions

DRUG: AG-348

Sponsor

Agios Pharmaceuticals, Inc.